摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-[4-(5-(3,5-dimethylphenyl)-4-{2-[4-(2-oxo-2-pyrrolidin-1-ylethyl)piperazin-1-yl]ethyl}-1H-pyrrol-3-yl)-2,2-dimethylbutanoyl]-7-azabicyclo[2.2.1]heptane | 863561-54-0

中文名称
——
中文别名
——
英文名称
7-[4-(5-(3,5-dimethylphenyl)-4-{2-[4-(2-oxo-2-pyrrolidin-1-ylethyl)piperazin-1-yl]ethyl}-1H-pyrrol-3-yl)-2,2-dimethylbutanoyl]-7-azabicyclo[2.2.1]heptane
英文别名
3-[3,3-dimethyl-4-oxo-4-(7-azabicyclo[2.2.1]heptan-7-yl)butyl]-4-[2-{4-(pyrrolidin-1-ylcarbonylmethyl)piperazin-1-yl}ethyl]-5-(3,5-dimethylphenyl)-1H-pyrrole;1-(7-azabicyclo[2.2.1]heptan-7-yl)-4-[5-(3,5-dimethylphenyl)-4-[2-[4-(2-oxo-2-pyrrolidin-1-ylethyl)piperazin-1-yl]ethyl]-1H-pyrrol-3-yl]-2,2-dimethylbutan-1-one
7-[4-(5-(3,5-dimethylphenyl)-4-{2-[4-(2-oxo-2-pyrrolidin-1-ylethyl)piperazin-1-yl]ethyl}-1H-pyrrol-3-yl)-2,2-dimethylbutanoyl]-7-azabicyclo[2.2.1]heptane化学式
CAS
863561-54-0
化学式
C36H53N5O2
mdl
——
分子量
587.849
InChiKey
SMFNXSJLHHVWDX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.3
  • 重原子数:
    43
  • 可旋转键数:
    10
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    62.9
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    7-[4-(5-(3,5-dimethylphenyl)-4-{2-[4-(2-oxo-2-pyrrolidin-1-ylethyl)piperazin-1-yl]ethyl}-1H-pyrrol-3-yl)-2,2-dimethylbutanoyl]-7-azabicyclo[2.2.1]heptaneN-氯代丁二酰亚胺 作用下, 以 四氢呋喃 为溶剂, 反应 16.0h, 以22%的产率得到2-chloro-3-[3,3-dimethyl-4-oxo-4-(7-azabicyclo[2.2.1]heptan-7-yl)butyl]-4-[2-{4-(pyrrolidin-1-ylcarbonylmethyl)piperazin-1-yl}ethyl]-5-(3,5-dimethylphenyl)-1H-pyrrole
    参考文献:
    名称:
    [EN] PYRROLE DERIVATIVES AS GONADOTROPIN RELEASING HORMONE (GNRH) ANTAGONISTS
    [FR] DERIVES DE PYRROLE UTILISES EN TANT QU'ANTAGONISTES DE L'HORMONE LIBERANT DE LA GONADOTROPHINE (GNRH)
    摘要:
    这项发明涉及一组新型噻吩-吡咯烯化合物,其化学式为(I),其中:R1、R2、R3、R4、M 和 R5 如规范中所定义,作为促性腺激素释放激素拮抗剂。化学式(I)的新型化合物也被要求。该发明还涉及所述化合物的药物配方、使用所述化合物的治疗方法以及所述化合物的制备方法。
    公开号:
    WO2005079805A1
  • 作为产物:
    描述:
    2-[2-(7-azabicyclo[2.2.1]hept-7-yl)-1,1-dimethyl-2-oxoethyl]-5-(3,5-dimethylphenyl)-4-{2-[4-(2-oxo-2-pyrrolidin-1-ylethyl)piperazin-1-yl]ethyl}-6H-thieno[2,3-b]pyrrole 在 乙醇 作用下, 反应 72.0h, 以35%的产率得到7-[4-(5-(3,5-dimethylphenyl)-4-{2-[4-(2-oxo-2-pyrrolidin-1-ylethyl)piperazin-1-yl]ethyl}-1H-pyrrol-3-yl)-2,2-dimethylbutanoyl]-7-azabicyclo[2.2.1]heptane
    参考文献:
    名称:
    Fischer synthesis of isomeric thienopyrrole LHRH antagonists
    摘要:
    As part of a structure-activity exploration into LHRH antagonists, structures containing the thieno[2,3b]pyrrole core were identified as potent antagonists. This letter describes the employment of the Fischer synthesis to access this thienopyrrole and isorneric final compounds. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2009.05.007
点击查看最新优质反应信息

文献信息

  • Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists
    申请人:Harris Steven Craig
    公开号:US20070185106A1
    公开(公告)日:2007-08-09
    The invention relates to a group of novel thieno-pyrrole compounds of formula (I) wherein: R 1 , R 2 , R 3 , R 4 M, and R 5 are as defined in the specification, as inter alia, gonadotrophin releasing hormone antagonists. Novel compounds of formula (I) are also claimed. The invention also relates to pharmaceutical formulations of said compounds, methods of treatment using said compounds and to processes for the preparation of said compounds.
查看更多